Clinical pharmacokinetics and pharmacodynamics of finasteride (Q41143972)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1996

edit

Language	Label	Description	Also known as
English	Clinical pharmacokinetics and pharmacodynamics of finasteride	scientific article published on January 1996

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Clinical pharmacokinetics and pharmacodynamics of finasteride (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

main subject

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

J F Steiner

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

publication date

1 January 1996

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

published in

Clinical Pharmacokinetics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

volume

30

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

page(s)

16-27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

cites work

High-performance liquid chromatographic determination of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a 4-azasteroid, in human plasma from a phase I study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Finasteride, a 5α-Reductase Inhibitor on Prostate Tissue Androgens and Prostate-Specific Antigen*

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Picogram determination of finasteride in human plasma and semen by high-performance liquid chromatography with atmospheric-pressure chemical-ionization tandem mass spectrometry

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scandinavian Clinical Study of Finasteride in the Treatment of Benign Prostatic Hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a new type of specific competitive inhibitor of testosterone 5 alpha-reductase, i

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year follow-up of patients with benign prostatic hyperplasia treated with finasteride.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urodynamic Effects of Finasteride in the Treatment of Bladder Outlet Obstruction due to Benign Prostatic Hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of drug therapy in the elderly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical development of a 5α-reductase inhibitor, finasteride

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case report: finasteride-induced gynecomastia in a 62-year-old man

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride for the treatment and control of benign prostatic hyperplasia: summary of phase III controlled studies. The Finasteride Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen Metabolism in Men Receiving Finasteride before Prostatectomy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of finasteride on adrenal steroidogenesis in men

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year experience in the treatment of benign prostatic hyperplasia with finasteride. The MK-906 (Finasteride) Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential activities of androgen metabolizing enzymes in human prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 5-Alpha-Reductase Inhibition on Sex-Hormone-Binding Globulin in Elderly Men

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of finasteride on prostate volume, urinary flow rate and symptom score in men with benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride, A Steroid 5α‐Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride: a 5 alpha-reductase inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5 alpha-reductase inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride: a slow-binding 5 alpha-reductase inhibitor.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long term treatment with finasteride (MK-906), a 5-alpha reductase inhibitor, on circulating LH, FSH, prolactin and estradiol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic modeling of finasteride, a 5 alpha-reductase inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5α-reductase inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8846625

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003088-199630010-00002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

Dimensions Publication ID

1012510585

0 references

Fatcat ID

release_k65uztaurzf3fcq37d74uuizqy

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/k65uztaurzf3fcq37d74uuizqy

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

8846625

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8846625

retrieved

27 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41143972&oldid=2204333677"